Related Experiment Videos
Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group
R A Karron1, R J Singleton, L Bulkow
1Center for Immunization Research, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205, USA. rkarron@jhsph.edu
Insights
Infants in Alaska's YK Delta experience extremely high hospitalization rates for respiratory syncytial virus (RSV), a leading cause of infant hospital admissions. Lower antibody levels in infants under six months were linked to severe RSV illness.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Respiratory syncytial virus (RSV) is a common cause of infant respiratory illness.
- Hospitalization rates for RSV vary globally, with limited data from remote Arctic regions.
- Previous research suggests certain infant populations may be at higher risk for severe RSV outcomes.
Purpose of the Study:
- To determine the incidence and severity of RSV hospitalizations in infants in the Yukon-Kuskokwim (YK) Delta, Alaska.
- To compare RSV disease severity between YK Delta infants and those at Johns Hopkins Hospital (JHH).
- To identify risk factors for severe RSV disease in YK Delta infants.
Main Methods:
- A 3-year prospective surveillance study was conducted in the YK Delta.
- Infant hospitalization data for RSV infection were collected and analyzed.
- RSV microneutralizing antibody titers were measured in YK Delta infants and correlated with disease severity.
Main Results:
- The annual RSV hospitalization rate for infants under 1 year in the YK Delta was 53-249/1000, significantly higher than general rates.
- RSV infection was the most frequent reason for infant hospitalization in the region.
- One in 125 infants required mechanical ventilation for RSV, and low antibody titers (<1200) in infants ≤6 months were associated with severe disease (OR=6.2, P=.03).
- Disease severity in non-high-risk YK Delta infants did not differ from JHH infants.
Conclusions:
- Infants in the YK Delta face a disproportionately high burden of RSV hospitalizations.
- Newborns in the YK Delta may be at increased risk for severe RSV illness.
- Lower RSV antibody titers in young infants are a potential indicator of severe disease risk.
Abstract:
Hospitalization rates for respiratory syncytial virus (RSV) infection range from 1 to 20/1000 infants. To determine the rate and severity of RSV infections requiring hospitalization for infants in the Yukon-Kuskokwim (YK) Delta of Alaska, a 3-year prospective surveillance study was conducted. The annual rate of RSV hospitalization for YK Delta infants <1 year of age was 53-249/1000. RSV infection was the most frequent cause of infant hospitalization. RSV disease severity did not differ among non-high-risk infants in the YK Delta and at Johns Hopkins Hospital (JHH). On average, 1/125 infants born in the YK Delta required mechanical ventilation for RSV infection. During the peak season, approximately $1034/child <3 years of age was spent on RSV hospitalization in the YK Delta. In YK Delta infants =6 months old, RSV microneutralizing antibody titers <1200 were associated with severe disease (odds ratio=6.2, P=.03). In the YK Delta and at JHH, newborns may be at greater risk for severe RSV illness than previously thought.